Anhui Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China.
Department of Nuclear Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, China.
Contrast Media Mol Imaging. 2022 Jan 30;2022:2586245. doi: 10.1155/2022/2586245. eCollection 2022.
Intratumor metabolic heterogeneity parameters on F-2-fluoro-2-deoxy-D-glucose (F-FDG) positron emission tomography-computed tomography (PET-CT) have been proven to be predictors of the clinical prognosis of cancer patients. The study aimed to examine the correlation between F-FDG PET-CT-defined heterogeneity parameters and the prognostic significance in patients with colorectal cancer.
The study included 188 patients with colorectal cancer who received surgery and F-FDG PET/CT examinations. Preoperative F-FDG PET/CT conventional and metabolic heterogeneity parameters were collected, including maximum, peak, and mean standardized uptake value (SUVmax, SUVpeak, and SUVmean), metabolic tumor volume (MTV), total lesion glycolysis (TLG), heterogeneity index-1 (HI-1) and heterogeneity index-2 (HI-2), and clinicopathological information. Correlations between these parameters and patient survival outcomes were inferred.
The associations between F-FDG PET/CT parameters and clinical outcomes were analyzed. Tumor thrombus ( < 0.001), tumor stage (=0.001), MTV (=0.003), HI-1 (=0.032), and HI-2 (=0.001) differed between the two groups with and without recurrence. Multivariate analysis showed that, in the radical surgery group, HI-2 (HR = 1.10, 95% CI: 1.04-1.17, =0.001), tumor stage (HR = 20.65, 95% CI: 4.81-88.62, < 0.001), and regional lymph nodes status (HR = 0.16, 95% CI: 0.04-0.57, =0.005) were independent variables significantly correlated with progression-free survival (PFS) and HI-2 (HR = 1.16, 95% CI: 1.07-1.26, < 0.001) was an independent variable affecting overall survival (OS). In the palliative surgery group, HI-2 (HR = 1.03, 95% CI: 1.01-1.06, =0.020) was an independent variable affecting PFS, and all the parameters were not statistically significant for OS.
HI-2, tumor stage, and regional lymph nodes status might predict the outcomes of colorectal cancer more effectively than other F-FDG PET/CT defined parameters.
在氟-2-脱氧-D-葡萄糖(F-FDG)正电子发射断层扫描-计算机断层扫描(PET-CT)上,肿瘤内代谢异质性参数已被证明是癌症患者临床预后的预测因子。本研究旨在探讨 F-FDG PET-CT 定义的异质性参数与结直肠癌患者预后意义之间的相关性。
本研究纳入了 188 例接受手术和 F-FDG PET/CT 检查的结直肠癌患者。收集了术前 F-FDG PET/CT 的常规和代谢异质性参数,包括最大标准摄取值(SUVmax)、峰值标准摄取值(SUVpeak)和平均标准摄取值(SUVmean)、代谢肿瘤体积(MTV)、总病灶糖酵解(TLG)、异质性指数-1(HI-1)和异质性指数-2(HI-2)以及临床病理信息。推断了这些参数与患者生存结果之间的相关性。
分析了 F-FDG PET/CT 参数与临床结局之间的关系。肿瘤栓子(<0.001)、肿瘤分期(=0.001)、MTV(=0.003)、HI-1(=0.032)和 HI-2(<0.001)在有和无复发的两组之间存在差异。多变量分析显示,在根治性手术组中,HI-2(HR=1.10,95%CI:1.04-1.17,=0.001)、肿瘤分期(HR=20.65,95%CI:4.81-88.62,<0.001)和区域淋巴结状态(HR=0.16,95%CI:0.04-0.57,=0.005)是与无进展生存期(PFS)显著相关的独立变量,而 HI-2(HR=1.16,95%CI:1.07-1.26,<0.001)是影响总生存期(OS)的独立变量。在姑息性手术组中,HI-2(HR=1.03,95%CI:1.01-1.06,=0.020)是影响 PFS 的独立变量,而所有参数对 OS 均无统计学意义。
与其他 F-FDG PET-CT 定义的参数相比,HI-2、肿瘤分期和区域淋巴结状态可能更有效地预测结直肠癌的结局。